Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQX: ERDCF) (“Erdene” or the “Company”) is pleased to publish its 2026 Letter to Shareholders authored by President and CEO, Peter Akerley. To ...

Jaguar Health, Inc. (“Jaguar”) develops novel proprietary prescription drugs sustainably derived from plants for people with complicated gastrointestinal (“GI”) disease states. Jaguar family companies ...

This is a livestream presentation. Attendees are advised to log in ahead of the start time. The Company will host a live Q&A session during the webcast; questions may be submitted in advance to ...

Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Electrovaya Inc. is set to host an ...

Webcast will be held Thursday, May 21, 2026, at 5:30 p.m. ETCAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc.

HPE (NYSE: HPE) will conduct a live audio webcast of the Investor Relations Summit at HPE Discover 2026 on June 16, 2026. HPE also invites investors to view additional live programming from the event, ...

The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at ...

Westgold advises that Wayne Bramwell (Managing Director & CEO), Tommy Heng (Chief Financial Officer) and Aaron Rankine (Chief Operating Officer), will present the results via webcast on Wednesday, 29 ...

Bunge Global SA (NYSE: BG) will host its 2026 Investor Day, “Origins to Opportunities,” on Tuesday, March 10, 2026, from 9 a.m. to noon EST. Company management will conduct a concurrent webcast to ...

Space for the event is limited and pre-registration is required. Analysts and investors interested in attending are encouraged to contact Investor Relations at investors@crowdstrike.com. A live ...

VANCOUVER, Washington, April 23, 2026 (GLOBE NEWSWIRE)-- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized ...